Literature DB >> 12668548

Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada.

Shelly Sarwal1, Tom Wong, Cathy Sevigny, Lai-King Ng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12668548      PMCID： PMC151996     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin--Quebec, 1994-1995.

Authors:  L Ringuette; T Trudeau; P Turcotte; K Yeung; R Rémis; L Perron; I Le Corre
Journal:  Can Commun Dis Rep       Date:  1996-08-01

Review 2.  The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi.

Authors:  C A Ison; J A Dillon; J W Tapsall
Journal:  Lancet       Date:  1998       Impact factor: 79.321

3.  Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-11-22       Impact factor: 17.586

4.  Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in British Columbia: an imported phenomenon.

Authors:  D Patrick; C Shaw; M L Rekart
Journal:  Can Commun Dis Rep       Date:  1995-08-15

5.  Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ontario, 1992-1994.

Authors:  N Harnett; S Brown; G Riley; R Terro; C Krishnan
Journal:  Can Commun Dis Rep       Date:  1995-02-15

6.  Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-09-22       Impact factor: 17.586

7.  Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-05-29       Impact factor: 17.586
  7 in total
  6 in total

1.  Gonorrhea treatment guidelines in Canada: 2004 update.

Authors:  Janice Mann; Rhonda Kropp; Tom Wong; Sylvie Venne; Barbara Romanowski
Journal:  CMAJ       Date:  2004-11-23       Impact factor: 8.262

2.  The laboratory diagnosis of Neisseria gonorrhoeae.

Authors:  Lai-King Ng; Irene E Martin
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

3.  Drug-resistant Neisseria gonorrhoeae in Michigan.

Authors:  Kathryn E Macomber; Martha S Boehme; James T Rudrik; Dara Ganoczy; Erin Crandell-Alden; William A Schneider; Patricia A Somsel
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

4.  Antimicrobial susceptibility profile of Gonococcal isolates obtained from men presenting with urethral discharge in Addis Ababa, Ethiopia: Implications for national syndromic treatment guideline.

Authors:  Surafel Fentaw; Rajiha Abubeker; Negga Asamene; Meseret Assefa; Yonas Bekele; Eyasu Tigabu
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

5.  Pilus phase variation switches gonococcal adherence to invasion by caveolin-1-dependent host cell signaling.

Authors:  Michaela Faulstich; Jan-Peter Böttcher; Thomas F Meyer; Martin Fraunholz; Thomas Rudel
Journal:  PLoS Pathog       Date:  2013-05-23       Impact factor: 6.823

6.  Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae.

Authors:  Kakoli Roy; Susan A Wang; Martin I Meltzer
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.